Skip to content

Effects of different changes of perfusion index under standardized stimulation on hemodynamics after endotracheal intubation

To compare the effects of different changes of perfusion index under standardized stimulation on hemodynamics after endotracheal intubation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052488
Enrollment
Unknown
Registered
2021-10-29
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients under general anesthesia

Interventions

Group A :The perfusion index changes in the range of 15% - 30%
Group B :The change of perfusion index was within 15%

Sponsors

The First Affiliated Hospital of Gannan Medical Uiversity
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-60 years old; 2. ASA grade I-II and cardiac function grade I-II. There were no serious cardiovascular and cerebrovascular diseases and no obvious abnormalities of liver and kidney function before operation; 3. They all volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of hypertension and diabetes; 2. Use vasoactive drugs to control hemodynamics, and those with vascular diseases, such as arteritis, Raynaud's disease, etc.; 3. Abnormal respiratory tract anatomy, difficult airway, ankylosing spondylitis and other difficult ventilation intubation, and those who need awake intubation; 4. Patients with respiratory failure, PaO250mmHg, acute asthma attack, and excessive phlegm; 5. Patients with cardiac insufficiency, those with heart failure who cannot lie supine, and those with uncontrolled angina pectoris; 6. Severe arrhythmia, heart valve disease, acute myocardial infarction or recent myocardial infarction; 7. Have a history of allergy to anesthetic drugs or infused liquids, and cannot cooperate with the researcher for various other reasons.

Design outcomes

Primary

MeasureTime frame
Perfusion index;arterial pressure;heart rate;

Countries

China

Contacts

Public ContactDeng Zihao

Gannan Medical University

dengzihao923@163.com+86 18379879830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026